---
figid: PMC6323006__nihms-997841-f0002
figlink: /pmc/articles/PMC6323006/figure/F2/
number: F2
caption: Inhibitors to specific mechanical and metabolic pathways. Experimentally
  proven reversal agents exist for inhibitors of the electron transport chain like
  rotenone (succinate), antimycin A (TMPD, ascorbate), oligomycin (FCCP), and cyanide
  (glucose). 2-Deoxyglucose competitively inhibits the production of glucose via the
  glycolytic pathway. Y-27632 and ML-7 act to inhibit the actin–myosin contraction
  machinery.
pmcid: PMC6323006
papertitle: Platelet biomechanics, platelet bioenergetics, and applications to clinical
  practice and translational research.
reftext: Mitchell J. George, et al. Platelets. 2018 Jul;29(5):431-439.
pmc_ranked_result_index: '61375'
pathway_score: 0.9521325
filename: nihms-997841-f0002.jpg
figtitle: Inhibitors to specific mechanical and metabolic pathways
year: '2018'
organisms:
- Rattus norvegicus
- Chlorocebus aethiops
- Homo sapiens
ndex: cc9b591e-ded3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6323006__nihms-997841-f0002.html
  '@type': Dataset
  description: Inhibitors to specific mechanical and metabolic pathways. Experimentally
    proven reversal agents exist for inhibitors of the electron transport chain like
    rotenone (succinate), antimycin A (TMPD, ascorbate), oligomycin (FCCP), and cyanide
    (glucose). 2-Deoxyglucose competitively inhibits the production of glucose via
    the glycolytic pathway. Y-27632 and ML-7 act to inhibit the actin–myosin contraction
    machinery.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACTA1
  - ACTG1
  - ACTC1
  - ROCK2
  - ACTA2
  - ACTB
  - ROCK1
  - WDTC1
  - SLC25A16
  - ACTG2
  - Y-27632
  - ADP
  - ATP
  - glucose
  - 2-deoxyglucose
  - Antimycin A
  - Rotenone
  - TMPD
  - ascorbate
  - Oligomycin
  - Succinate
  - OXIDATIVE
genes:
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: ML-7
  symbol: ML7
  source: hgnc_alias_symbol
  hgnc_symbol: SLC25A16
  entrez: '8034'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
chemicals:
- word: Y-27632
  source: MESH
  identifier: C108830
- word: ADP
  source: MESH
  identifier: D000244
- word: ATP
  source: MESH
  identifier: D000255
- word: glucose
  source: MESH
  identifier: D005947
- word: 2-deoxyglucose
  source: MESH
  identifier: D003847
- word: Antimycin A
  source: MESH
  identifier: C032456
- word: Rotenone
  source: MESH
  identifier: D012402
- word: TMPD
  source: MESH
  identifier: C524030
- word: ascorbate
  source: MESH
  identifier: D001205
- word: Oligomycin
  source: MESH
  identifier: C031004
- word: Succinate
  source: MESH
  identifier: D013386
diseases:
- word: OXIDATIVE
  source: MESH
  identifier: D004194
figid_alias: PMC6323006__F2
redirect_from: /figures/PMC6323006__F2
figtype: Figure
---
